Swiss Re’s Idexx Laboratories IDXX Stock Holding History

Swiss Re’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$175K	Buy	332 +312	+1,560%	+$175K	0.02%	141
2026 Q1	$11.2K	Hold	20	–	–	0.07%	202
2025 Q4	$13.5K	Buy	+20	New	+$13.6K	﹤0.01%	187

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Swiss Re's IDXX Position: Q2 2026 in Review

Swiss Re increased its Idexx Laboratories (IDXX) stake by 1,560% in Q2 2026, buying an estimated $175K and bringing the position to 332 shares worth $175K. The position accounts for 0.02% of the portfolio, ranked #141.

Swiss Re first reported a position in IDXX in Q4 2025 and has held it in 3 quarters since. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Swiss Re held 332 shares of Idexx Laboratories worth $175K as of Q2 2026.
Swiss Re bought 312 Idexx Laboratories shares in Q2 2026, an estimated $175K.
Idexx Laboratories made up 0.02% of Swiss Re's portfolio in Q2 2026, its #141 holding.
Swiss Re first reported a position in Idexx Laboratories in Q4 2025 and has held it in 3 quarters since.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Swiss Re's 13F filing for Q2 2026, filed 11 Aug 2026.